semaglutide and plaquenil Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association Can GLP-1 Medications Be Considered – semaglutide and plaquenil Pacific-AA Online

Yes, any new or unusual skin reactions should be reported to your GP or diabetes specialist nurse for proper assessment

a statistically significantly higher duration of base rigidity was observed with sildenafil and IN PT-141 multiple agent therapy compared to sildenafil and IN placebo spray, or compared to placebo and IN PT-141

Tirzepatide, a dual GLP-1 and GIP receptor agonist, showed even stronger results in the SURMOUNT trialsup to 22.5% weight loss at the highest doseagain without needing additional agents

Dose Escalation and Titration: Many side effects occur when treatment starts or doses increase

Overall safety profile: Pooled trial data showed no meaningful rise in overall adverse events versus placebo [6] [7]

Affected individuals may show other non-motor symptoms, with some being GI-oriented and emerging years before the classical motor features (Cersosimo et al., 2013)